China: Special Drug Approval Certificate – Electronic License Access Update
Streamlined Access to NMPA Electronic Drug Approval Certificates
Effective from 17-Nov-2025
Electronic license access available since 26-Mar-2024
NMPA | Pharmaceuticals | Regulatory AffairsJFDA Issues Circular on Analysis Requirements for Post-Marketing Products
Post-marketing surveillance analysis requirements for controlled products and compliance with laboratory testing before distribution.
JFDA | Pharmaceuticals | Regulatory AffairsChina: Draft Guidelines for Manufacturing & Testing of Recombinant Monoclonal Antibody Biopharmaceuticals Open for Public Comment
Strengthening standardization in biologics manufacturing & QC
Released on November 10, 2025 Open until 09-Jan-2026
NMPA | Pharmaceuticals | Regulatory AffairsSaudi Arabia: SFDA Enhances Collaboration with Health Authorities to Advance Medicine Safety
Advancing national drug quality & adverse event reporting
Released on November 11, 2025
SFDA | Pharmaceuticals | Regulatory AffairsSaudi Arabia: Guideline on Requirements for Biosimilar Development & Approval
Stay Compliant with SFDA’s Latest Biosimilar Requirements
Effective from 10-Nov-2025 Open for public comment until 09-Jan-2026
SFDA | Pharmaceuticals | Regulatory Affairs
Consult
